Literature DB >> 33242205

Systemic mastocytosis revisited with an emphasis on skeletal manifestations.

Antonio Leone1, Marianna Criscuolo2, Consolato Gullì2, Antonella Petrosino2, Nicola Carlo Bianco2, Cesare Colosimo2.   

Abstract

Systemic mastocytosis (SM) is a rare form of mastocytosis that can affect various organ systems. Bone involvement is the most common and prominent imaging feature in patients with SM regardless of the subtype. Furthermore, bone involvement is a prognostic factor as it may entail an aggressive course of the disease. Diagnosis is established by bone marrow biopsy complemented by imaging modalities such as radiography, CT, and magnetic resonance (MR) imaging. The radiographic and CT appearances are that of sclerotic, lytic, or mixed patterns with focal or diffuse distribution, involving primarily the axial skeleton and the ends of the long bones. Bone marrow infiltration is best recognized on MR imaging. Osteoporosis is common in SM; thus, a bone mineral density measurement at lumbar spine and proximal femur by dual-energy X-ray absorptiometry should be obtained. Imaging plays a huge part in the diagnostic process; when skeletal imaging findings are carefully interpreted and correlated with clinical features, they can lead to the suspicion of SM. The primary aims of this review article were to focus on the role of imaging in detection and characterization of skeletal patterns of SM and to discuss relevant clinical features that could facilitate prompt and correct diagnosis.

Entities:  

Keywords:  Bone marrow; CT; Magnetic resonance imaging; Radiography; Systemic mastocytosis

Mesh:

Year:  2020        PMID: 33242205     DOI: 10.1007/s11547-020-01306-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  59 in total

Review 1.  Systemic mastocytosis.

Authors:  Cem Akin; Dean D Metcalfe
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

2.  Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.

Authors:  Animesh Pardanani
Journal:  Am J Hematol       Date:  2019-01-02       Impact factor: 10.047

3.  Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13).

Authors:  A S Kirshenbaum; J P Goff; T Semere; B Foster; L M Scott; D D Metcalfe
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

Review 4.  Pathogenesis, clinical features, and treatment advances in mastocytosis.

Authors:  A Pardanani; C Akin; P Valent
Journal:  Best Pract Res Clin Haematol       Date:  2006       Impact factor: 3.020

5.  Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells.

Authors:  A S Kirshenbaum; S W Kessler; J P Goff; D D Metcalfe
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism.

Authors:  Y Amagai; A Tanaka; A Matsuda; K Jung; K Ohmori; H Matsuda
Journal:  J Leukoc Biol       Date:  2012-11-02       Impact factor: 4.962

Review 8.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

Review 9.  Mast Cell: A Multi-Functional Master Cell.

Authors:  Melissa Krystel-Whittemore; Kottarappat N Dileepan; John G Wood
Journal:  Front Immunol       Date:  2016-01-06       Impact factor: 7.561

Review 10.  Mast cell sarcoma: new cases and literature review.

Authors:  Jilliana Monnier; Sophie Georgin-Lavialle; Danielle Canioni; Ludovic Lhermitte; Michael Soussan; Michel Arock; Julie Bruneau; Patrice Dubreuil; Christine Bodemer; Marie-Olivia Chandesris; Olivier Lortholary; Olivier Hermine; Gandhi Damaj
Journal:  Oncotarget       Date:  2016-10-04
View more
  2 in total

1.  Pulmonary Lymphangitis Poses a Major Challenge for Radiologists in an Oncological Setting during the COVID-19 Pandemic.

Authors:  Roberta Fusco; Igino Simonetti; Stefania Ianniello; Alberta Villanacci; Francesca Grassi; Federica Dell'Aversana; Roberta Grassi; Diletta Cozzi; Eleonora Bicci; Pierpaolo Palumbo; Alessandra Borgheresi; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  J Pers Med       Date:  2022-04-12

Review 2.  Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.

Authors:  Clayton Webster Jackson; Cristina Marie Pratt; Chase Preston Rupprecht; Debendra Pattanaik; Guha Krishnaswamy
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.